ProCE Banner Activity

SGLT2 Inhibitors for People With Heart Failure

PDF

This infographic highlights the benefits of SGLT2 inhibitors for heart failure patients, emphasizing their role in reducing hospitalization rates, improving heart function, and enhancing overall quality of life.

Released: September 23, 2024

Expiration: September 22, 2025

Share

Faculty

Lauren S. Eyadiel

Lauren S. Eyadiel, MS, MMS, CCC, SLP, PA-C, FHFSA

Assistant Professor, Heart Failure – Certified
Department of PA Studies, Wake Forest University School of Medicine
Advanced Heart Failure, Heart Transplant, and Mechanical Circulatory Support
Atrium Health Wake Forest Baptist
Winston-Salem, North Carolina

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

This activity is supported by an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company.

Boehringer Ingelheim Pharmaceuticals, Inc.

Eli Lilly and Company

Disclosure

Primary Author

Lauren S. Eyadiel, MS, MMS, CCC, SLP, PA-C, FHFSA

Assistant Professor, Heart Failure – Certified
Department of PA Studies, Wake Forest University School of Medicine
Advanced Heart Failure, Heart Transplant, and Mechanical Circulatory Support
Atrium Health Wake Forest Baptist
Winston-Salem, North Carolina

Lauren S. Eyadiel, MS, MMS, CCC, SLP, PA-C, FHFSA, has no relevant financial relationships to disclose.